ADME
ADME is the four-letter abbreviation (acronym) for
ADME, describes the
are also considered, yielding LADME, ADMET, or LADMET.Components
Absorption/administration
For a compound to reach a tissue, it usually must be taken into the
Distribution
The compound needs to be carried to its effector site, most often via the bloodstream. From there, the compound may distribute into muscle and organs, usually to differing extents. After entry into the systemic circulation, either by
Distribution is defined as the reversible transfer of a drug between one compartment to another. Some factors affecting drug distribution include regional blood flow rates, molecular size, polarity and binding to serum proteins, forming a complex. Distribution can be a serious problem at some natural barriers like the blood–brain barrier.
Metabolism
Compounds begin to break down as soon as they enter the body. The majority of small-molecule drug metabolism is carried out in the liver by redox enzymes, termed cytochrome P450 enzymes. As metabolism occurs, the initial (parent) compound is converted to new compounds called metabolites. When metabolites are pharmacologically inert, metabolism deactivates the administered dose of parent drug and this usually reduces the effects on the body. Metabolites may also be pharmacologically active, sometimes more so than the parent drug (see prodrug).
Excretion
Compounds and their metabolites need to be removed from the body via excretion, usually through the kidneys (urine) or in the feces. Unless excretion is complete, accumulation of foreign substances can adversely affect normal metabolism.
There are three main sites where drug excretion occurs. The kidney is the most important site and it is where products are excreted through urine. Biliary excretion or fecal excretion is the process that initiates in the liver and passes through to the gut until the products are finally excreted along with waste products or feces. The last main method of excretion is through the lungs (e.g. anesthetic gases).
Excretion of drugs by the kidney involves 3 main mechanisms:
- Glomerular filtrationof unbound drug.
- Active secretion of (free & protein-bound) drug by transporters (e.g. anions such as .
- Filtrate 100-fold concentrated in tubules for a favorable concentration gradient so that it may be secreted by passive diffusion and passed out through the urine.
Toxicity
Sometimes, the potential or real
The route of administration critically influences ADME.
See also
References
- Balani SK, Miwa GT, Gan LS, Wu JT, Lee FW (2005). "Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection". Current Topics in Medicinal Chemistry. 5 (11): 1033–1038. PMID 16181128.
- Singh SS (February 2006). "Preclinical pharmacokinetics: an approach towards safer and efficacious drugs". Current Drug Metabolism. 7 (2): 165–182. PMID 16472106.
- Tetko IV, Bruneau P, Mewes HW, Rohrer DC, Poda GI (August 2006). "Can we estimate the accuracy of ADME-Tox predictions?" (pre-print). Drug Discovery Today. 11 (15–16): 700–707. PMID 16846797.
- PMID 25083246.